Ypsomed Holding AG (FRA:OWX) FFO


FRA:OWX Ypsomed Holding AG FRA:OWX
86 GF Score
Price €387.80
GF Value €433.84
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

FRA:OWX
86GF Score
Ypsomed Holding AG FRA:OWX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (FRA:OWX) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of €387.80 is trading 10.6% below its estimated GF Value™ of €433.84. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for FRA:OWX:

  • FFO:
  • GF Value™: €433.84 vs. price of €387.80 (10.6% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the FRA:OWX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
86GF Score

Get the complete analysis for FRA:OWX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€387.80
Price
€433.84
GF Value